573 related articles for article (PubMed ID: 17939897)
21. The impact of varicella vaccination in the United States.
Hambleton S; Gershon AA
Semin Pediatr Infect Dis; 2005 Jan; 16(1):38-43. PubMed ID: 15685148
[TBL] [Abstract][Full Text] [Related]
22. Varicella vaccine and infection with varicella-zoster virus.
Vázquez M; Shapiro ED
N Engl J Med; 2005 Feb; 352(5):439-40. PubMed ID: 15689581
[No Abstract] [Full Text] [Related]
23. Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
[TBL] [Abstract][Full Text] [Related]
24. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
25. Varicella zoster vaccines.
Creed R; Satyaprakash A; Ravanfar P
Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
[TBL] [Abstract][Full Text] [Related]
26. [Varicella disease and varicella vaccine. A literature review].
Frederiksen MS; Plesner AM; Stellfeld M
Ugeskr Laeger; 2003 Jun; 165(23):2387-91. PubMed ID: 12840997
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Varicella-Zoster Virus in England and Wales.
Brisson M; Edmunds WJ
J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
[TBL] [Abstract][Full Text] [Related]
28. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
Gao Z; Gidding HF; Wood JG; MacIntyre CR
Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
[TBL] [Abstract][Full Text] [Related]
29. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
Carville KS; Riddell MA; Kelly HA
Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of varicella hospitalizations in the United States, 1995-2005.
Reynolds MA; Watson BM; Plott-Adams KK; Jumaan AO; Galil K; Maupin TJ; Zhang JX; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S120-6. PubMed ID: 18419384
[TBL] [Abstract][Full Text] [Related]
31. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.
Lin F; Hadler JL
J Infect Dis; 2000 Jun; 181(6):1897-905. PubMed ID: 10837168
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
34. Loss of vaccine-induced immunity to varicella over time.
Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
[TBL] [Abstract][Full Text] [Related]
35. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
36. [Chickenpox: sufficient reasons for the introduction of vaccination].
Rümke H; de Groot R
Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2630-2. PubMed ID: 17205937
[TBL] [Abstract][Full Text] [Related]
37. Decline in annual incidence of varicella--selected states, 1990-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(37):884-5. PubMed ID: 13679791
[TBL] [Abstract][Full Text] [Related]
38. Varicella vaccine for prevention of chickenpox.
Dennehy PH
R I Med; 1995 Jan; 78(1):14-6. PubMed ID: 7873808
[TBL] [Abstract][Full Text] [Related]
39. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.
Edgar BL; Galanis E; Kay C; Skowronski D; Naus M; Patrick D
Can Commun Dis Rep; 2007 Nov; 33(11):1-15. PubMed ID: 18163240
[No Abstract] [Full Text] [Related]
40. Cost-effectiveness of varicella vaccination programs: an update of the literature.
Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
